← Back to Search

Behavioral Intervention

Mindfulness Oriented Recovery Enhancement + Patient-centered chronic pain management visits for Chemically-Induced Disorders

N/A

Waitlist Available

Research Sponsored by University of Utah

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Current use of opioids for ≥3 months

Age 18 +

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change from baseline through study completion (assessed at 3-, 6-, 9-, and 12-months follow-up)

Awards & highlights

Study Summary

"This trial aims to see if using Mindfulness-Oriented Recovery Enhancement (MORE) and patient-centered chronic pain management visits can help reduce chronic pain, improve quality of life, and lessen the negative effects

Who is the study for?

This trial is for individuals with chronic pain who are currently on long-term opioid therapy. It's aimed at those experiencing substance use disorders, neurologic symptoms, or mental illness related to narcotic use. Specific eligibility criteria were not provided.Check my eligibility

What is being tested?

The study tests the effectiveness of Mindfulness-Oriented Recovery Enhancement (MORE) and patient-centered chronic pain management visits in primary care settings to alleviate chronic pain, enhance life quality, and minimize opioid misuse.See study design

What are the potential side effects?

Since this trial involves mindfulness practices and patient-centered visits rather than medication, typical drug side effects aren't expected. However, participants may experience emotional discomfort or distress during the process.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been using opioids for 3 months or more.

Select...

I am 18 years old or older.

Select...

I have been diagnosed with chronic pain lasting more than 3 months.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change from baseline through study completion (assessed at 3-, 6-, 9-, and 12-months follow-up)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change from baseline through study completion (assessed at 3-, 6-, 9-, and 12-months follow-up)

This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline through study completion (assessed at 3-, 6-, 9-, and 12-months follow-up) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Chronic Pain

Opioid Misuse

Secondary outcome measures

Change in Quality of Life

Depression

Generalized Anxiety

+3 more

Other outcome measures

Decentering

Mindful Reappraisal of Pain Sensations

Reappraisal

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Mindfulness Oriented Recovery Enhancement + Patient-centered chronic pain management visitsExperimental Treatment2 Interventions

Participants will attend a Mindfulness-Oriented Recovery Enhancement (MORE) group weekly for eight weeks, in addition to patient-centered chronic pain management visits led by their primary care provider.

Group II: Patient-centered chronic pain management visitsActive Control1 Intervention

Participants will attend patient-centered chronic pain management visits led by their primary care provider.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Mindfulness Oriented Recovery Enhancement

2020

N/A

~190

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of UtahLead Sponsor

1,102 Previous Clinical Trials

1,778,961 Total Patients Enrolled

Rutgers UniversityOTHER

114 Previous Clinical Trials

2,804,093 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available openings for patients to participate in this study?

"Information from clinicaltrials.gov shows that this particular study is no longer accepting new participants. Although it was initially listed on May 6th, 2024 and last updated on April 23rd, 2024, there are currently an impressive total of 1654 other trials actively seeking candidates for participation."

Answered by AI

What is the main objective of this medical study?

"This clinical trial aims to assess Chronic pain over the course of 3, 6, 9, and 12 months from baseline. Secondary outcomes include evaluating Generalized Anxiety using the GAD-7 scale (ranging from 0-21), monitoring Opioid Dosing through TLFB interviews converted into morphine-equivalent doses, and tracking changes in Quality of Life via PROMIS-29 covering various domains like physical function, anxiety, depression, fatigue, sleep disturbance, social participation ability, pain interference,and pain intensity (scoring between 4-20 with higher scores indicating greater impairment)."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits

Eric Garland 2024. "Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06387290.

All > Substance Abuse > Mental Health